
Novo Nordisk A/S NVO
€ 33.19
-1.33%
Geschäftsbericht 2025
hinzugefügt 28.02.2026
Novo Nordisk A/S P/S 2011-2026 | NVO
P/S Jährlich Novo Nordisk A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.83 | 1.28 | 1.08 | 6.43 | 7.93 | 5.11 | 8.41 | 8.31 | 7.79 | 8.22 | 6.26 |
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.41 | 1.08 | 5.7 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.44 | -4.32 % | $ 1.03 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
ADMA Biologics
ADMA
|
7.41 | $ 15.36 | -2.17 % | $ 3.66 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.28 | 0.65 % | $ 2.56 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.51 | 1.35 % | $ 385 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 14.05 | -1.44 % | $ 206 M | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 74.36 | -1.64 % | $ 1.44 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 162.43 | 0.6 % | $ 8.08 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 8.49 | -0.18 % | $ 1.75 B | ||
|
BridgeBio Pharma
BBIO
|
26.1 | $ 65.66 | -0.78 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 61.3 | 1.21 % | $ 11.8 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 7.79 | -5.75 % | $ 1.28 B | ||
|
CymaBay Therapeutics
CBAY
|
110 | - | - | $ 3.45 B | ||
|
Codexis
CDXS
|
4.91 | $ 1.23 | -2.38 % | $ 90.3 M | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 3.18 | -0.16 % | $ 3.71 M | ||
|
Checkpoint Therapeutics
CKPT
|
3.91 K | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M |